Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
119 PfennigT.KullmannE.ZavelT.NakielskiA.EbenhhO.ervenJ.et al
K.MarcinkoK.DesjardinsE
Novo is seeking an injunction and corrective ads
noted a regression of Dupuytrens disease in patients undergoing treatment of Hodgkins disease with procarbazine, thereby suggesting its use in a disease with proliferation of connective tissue (22)
While treatment decisions remain grounded in clinical need and professional guidance, growing awareness and adoption mean that patients are increasingly considering factors such as brand, value, efficacy, convenience and trust
(intraperitoneally))
US$ 27.28
US$ 25.18
US$ 26.69
US$ 29.56
US$ 27.64
US$ 23.11
US$ 26.80
US$ 25.69
US$ 25.49
US$ 26.48
US$ 25.36
US$ 25.41
